Does circulating progesterone mediate the associations of single nucleotide polymorphisms in progesterone receptor (PGR)-related genes with mammographic breast density in premenopausal women?

被引:3
作者
Akinjiyan, Favour A. [1 ]
Han, Yunan [2 ,3 ]
Luo, Jingqin [2 ,4 ,5 ]
Toriola, Adetunji T. [2 ,4 ,5 ]
机构
[1] Washington Univ, Med Scientist Training Program, Sch Med, St Louis, MO 63110 USA
[2] Washington Univ, Dept Surg, Div Publ Hlth Sci, Sch Med, Campus Box 8100,660 South Euclid Ave, St Louis, MO 63110 USA
[3] China Med Univ, Dept Breast Surg, Hosp 1, Shenyang 110001, Liaoning, Peoples R China
[4] Barnes Jewish Hosp, Alvin J Siteman Canc Ctr, St Louis, MO 63110 USA
[5] Washington Univ, Sch Med, St Louis, MO 63110 USA
关键词
Progesterone; Genetics; Mammographic breast density; SNPs; Breast; Premenopausal; ESTROGEN-PLUS-PROGESTIN; CANCER RISK; HORMONE-THERAPY; PROLIFERATION; PATTERNS;
D O I
10.1007/s12672-021-00438-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Progesterone is a proliferative hormone in the breast but the associations of genetic variations in progesterone-regulated pathways with mammographic breast density (MD) in premenopausal women and whether these associations are mediated through circulating progesterone are not clearly defined. We, therefore, investigated these associations in 364 premenopausal women with a median age of 44 years. We sequenced 179 progesterone receptor (PGR)-related single nucleotide polymorphisms (SNPs). We measured volumetric percent density (VPD) and non-dense volume (NDV) using Volpara. Linear regression models were fit on circulating progesterone or VPD/NDV separately. We performed mediation analysis to evaluate whether the effect of a SNP on VPD/NDV is mediated through circulating progesterone. All analyses were adjusted for confounders, phase of menstrual cycle and the Benjamini-Hochberg false discovery (FDR) adjusted p-value was applied to correct for multiple testing. In multivariable analyses, only PGR rs657516 had a direct effect on VPD (averaged direct effect estimate = - 0.20, 95%CI =- 0.38 similar to- 0.04, p-value = 0.02) but this was not statistically significant after FDR correction and the effect was not mediated by circulating progesterone (mediation effect averaged across the two genotypes= 0.01, 95%CI = -0.02 similar to 0.03, p-value= 0.70). Five SNPs (PGR rs11571241, rs11571239, rs1824128, rs11571150, PGRMC1 rs41294894) were associated with circulating progesterone but these were not statistically significant after FDR correction. SNPs in PGR-related genes were not associated with VPD, NDV and circulating progesterone did not mediate the associations, suggesting that the effects, if any, of these SNPs on MD are independent of circulating progesterone.
引用
收藏
页数:14
相关论文
共 50 条
[1]   Adiposity at Age 10 and Mammographic Density among Premenopausal Women [J].
Alimujiang, Aliya ;
Imm, Kellie R. ;
Appleton, Catherine M. ;
Colditz, Graham A. ;
Berkey, Catherine S. ;
Toriola, Adetunji T. .
CANCER PREVENTION RESEARCH, 2018, 11 (05) :287-293
[2]   Hormone replacement therapy and mammographic density: a systematic literature review [J].
Azam, Shadi ;
Jacobsen, Katja Kemp ;
Aro, Arja R. ;
Lynge, Elsebeth ;
Andersen, Zorana Jovanovic .
BREAST CANCER RESEARCH AND TREATMENT, 2020, 182 (03) :555-579
[3]   Progesterone regulates the proliferation of breast cancer cells - in vitro evidence [J].
Azeez, Juberiya M. ;
Sithul, Hima ;
Hariharan, Indhu ;
Sreekumar, Sreeja ;
Prabhakar, Jem ;
Sreeja, Sreeharshan ;
Pillai, Madhavan Radhakrishna .
DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 :5987-5999
[4]   Circulating Hormones and Mammographic Density in Premenopausal Women [J].
Bertrand, Kimberly A. ;
Eliassen, A. Heather ;
Hankinson, Susan E. ;
Rosner, Bernard A. ;
Tamimi, Rulla M. .
HORMONES & CANCER, 2018, 9 (02) :117-127
[5]   Fasting insulin and endogenous hormones in relation to premenopausal breast density (Canada) [J].
Borugian, Marilyn J. ;
Spinelli, John J. ;
Gordon, Paula B. ;
Abanto, Zenaida ;
Brooks-Wilson, Angela ;
Pollak, Michael N. ;
Warren, Linda J. ;
Hislop, T. Gregory ;
Gallagher, Richard P. .
CANCER CAUSES & CONTROL, 2014, 25 (03) :385-394
[6]   Heritability of mammographic density, a risk factor for breast cancer [J].
Boyd, NF ;
Dite, GS ;
Stone, J ;
Gunasekara, A ;
English, DR ;
McCredie, MRE ;
Giles, GG ;
Tritchler, D ;
Chiarelli, A ;
Yaffe, MJ ;
Hopper, JL .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (12) :886-894
[7]   The association of breast mitogens with mammographic densities [J].
Boyd, NF ;
Stone, J ;
Martin, LJ ;
Jong, R ;
Fishel, E ;
Yaffe, M ;
Hammond, G ;
Minkin, S .
BRITISH JOURNAL OF CANCER, 2002, 87 (08) :876-882
[8]   Comparison of Clinical and Automated Breast Density Measurements: Implications for Risk Prediction and Supplemental Screening [J].
Brandt, Kathleen R. ;
Scott, Christopher G. ;
Ma, Lin ;
Mahmoudzadeh, Amir P. ;
Jensen, Matthew R. ;
Whaley, Dana H. ;
Wu, Fang Fang ;
Malkov, Serghei ;
Hruska, Carrie B. ;
Norman, Aaron D. ;
Heine, John ;
Shepherd, John ;
Pankratz, V. Shane ;
Kerlikowske, Karla ;
Vachon, Celine M. .
RADIOLOGY, 2016, 279 (03) :710-719
[9]   A paracrine role for the epithelial progesterone receptor in mammary gland development [J].
Brisken, C ;
Park, S ;
Vass, T ;
Lydon, JP ;
O'Malley, BW ;
Weinberg, RA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (09) :5076-5081
[10]   Polymorphism in CYP17, GSTM1 and the progesterone receptor genes and its relationship with mammographic density [J].
Chambo, D. ;
Kemp, C. ;
Costa, A. M. M. ;
Souza, N. C. N. ;
Guerreiro da Silva, I. D. C. .
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2009, 42 (04) :323-329